News

Cantargia Reports New Results from Clinical Studies Investigating Nadunolimab in Several Forms of Cancer; Supporting Ongoing Strategies

LUND, SE / ACCESSWIRE / October 28, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB); (Nasdaq Stockholm:CANTA) today announced new clinical…

4 weeks ago

Pharmacy Healthy and Information Technology (PHIT) Collaborative Announces New Executive Director Jeff Rochon

ALEXANDRIA, VA / ACCESSWIRE / October 28, 2024 / The Executive Committee of the Pharmacy Health and Information Technology (PHIT)…

4 weeks ago

CBIH Strengthens Competitive Advantage with Rapid Expansion of Patent Filings

Houston, Texas--(Newsfile Corp. - October 28, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) trading on the OTC Markets under the…

4 weeks ago

MentalHealth.com Launches Mental Health Network

SAN FRANCISCO, CA / ACCESSWIRE / October 28, 2024 / Leading health technology company MentalHealth.com is proud to announce the…

4 weeks ago

CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / October 28, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company…

4 weeks ago

Ainos Expands Patent Portfolio With Strategic Shareholder’s Cutting-Edge Technology Assets

Strengthens AI Nose Gas Sensing Technology with Additional Exclusively Licensed PatentsSecures Exclusive Rights to Breakthrough Nitrogen-Oxygen Separation Technology with Superior…

4 weeks ago

Tenon Medical(R) Regains Full Compliance with Nasdaq Continued Listing Requirements

LOS GATOS, CA / ACCESSWIRE / October 28, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company…

4 weeks ago

MIRA Pharmaceuticals’ Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain

Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be Presented at…

4 weeks ago

IRLAB: Invitation to the Interim Report for Q3 2024 Presentation and Webcast

GOTHENBURG, SWEDEN / ACCESSWIRE / October 28, 2024 / IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing…

4 weeks ago

NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements

ZURICH, SWITZERLAND / ACCESSWIRE / October 28, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage…

4 weeks ago